Results 91 to 100 of about 4,601 (147)

Acid sphingomyelinase deficiency: Phenotypic, biochemical, and molecular heterogeneity in a series of 47 Iraqi patients from a single center. [PDF]

Mol Genet Metab Rep
Farhan R, Al-Tai M, Ahmed IA, Kareem A, Baheer S, Sadik BM, Jafar MM, Alothman MS.   +7 more
europepmc   +1 more source

Proteomic Profiling of an Exosome-Enriched Extracellular Vesicle Fraction and Structural Characterization of SMPDL3A in the Carcinogenic Liver Fluke <i>Clonorchis sinensis</i>. [PDF]

Int J Mol Sci
Kim SH, Yang D, Bae YA.
europepmc   +1 more source

Contradictory Effects on Hepatocytes in ASMD. [PDF]

Int J Mol Sci
Sysoev M, Solovyov D, Shestopalov A, Kutsev S.   +3 more
europepmc   +1 more source

Zuclopenthixol inhibits residual activity of acid sphingomyelinase in Niemann pick disease type B: a case report with in vitro validation. [PDF]

Orphanet J Rare Dis
Schiller M, Steiner KM, Bonnet U, Gulbins E, Scherbaum N.   +4 more
europepmc   +1 more source

A novel prenylflavonoid with efficacy in cancer therapy by targeting ceramide-orchestrated signaling. [PDF]

Front Pharmacol
Du R, Zhang C, Lei H, Gao X, Xiang Q, Zhang Z, Dai Y, Li X, Zhang L, Chen G.   +9 more
europepmc   +1 more source

Neutral sphingomyelinases restrict natural killer cells activity against lung cancer. [PDF]

Cancer Immunol Immunother
Cinotti R, Geindreau M, Bergqvist A, Yang Y, Lundqvist A.   +4 more
europepmc   +1 more source

Pathogenic Variants and Olipudase Alfa Treatment of Patients With Acid Sphingomyelinase Deficiency in Taiwan. [PDF]

Mol Genet Genomic Med
Lin HH, Chen HA, Lin SJ, Hsu RH, Lee NC, Hwu WL, Ni YH, Chou YY, Chiu PC, Peng SS, Chien YH.   +10 more
europepmc   +1 more source

SMPD1-mediated sphingolipid metabolism dysregulation in predicting and preventing in-stent restenosis of coronary heart disease patients. [PDF]

J Pharm Anal
Meng W, Sha Y, Zhong-Ga CR, Pan H, Zhai X, Zhen P, Tong HHY, Lao EPL, Zhang H, Yang W, Cui S, Song X, Li K.   +12 more
europepmc   +1 more source

Alkaline sphingomyelinase (ENPP7) attenuates DSS-induced colitis by modulating FOXO1-mediated antioxidative stress responses. [PDF]

BMC Gastroenterol
Cao W, Cheng Y, Wang X, Wang L, Li R, Pei S, Zhang G, Petersen JD, Zhang P.   +8 more
europepmc   +1 more source

Comment on "SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis" critical considerations on biomarker validation and Supraphysiological drug concentrations. [PDF]

J Transl Med
Chen J, Yan L.
europepmc   +1 more source